Assessing Clinical Outcomes in Alzheimer's Disease Agitation

PHASE3CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

December 31, 2020

Primary Completion Date

November 21, 2022

Study Completion Date

November 21, 2022

Conditions
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation,Psychomotor
Interventions
DRUG

AXS-05

AXS-05 tablets, taken twice daily

DRUG

Placebo

Placebo tablets, taken twice daily

Trial Locations (63)

10036

Clinical Research Site, New York

11229

Clinical Research Site, Brooklyn

12553

Clinical Research Site, New Windsor

13057

Clinical Research Site, East Syracuse

19046

Clinical Research Site, Jenkintown

19104

Clinical Research Site, Philadelphia

28211

Clinical Research Site, Charlotte

28601

Clinical Research Site, Hickory

30024

Clinical Research Site, Suwanee

30912

Clinical Research Site, Augusta

31909

Clinical Research Site, Columbus

32055

Clinical Research Site, Lake City

32502

Clinical Research Site, Pensacola

32807

Clinical Research Site, Orlando

32819

Clinical Research Site, Orlando

33012

Clinical Research Site, Hialeah

33014

Clinical Research Site, Miami Lakes

33024

Clinical Research Site, Pembroke Pines

33067

Clinical Research Site, Coral Springs

33155

Clinical Research Site, Miami

33175

Clinical Research Site, Miami

33351

Clinical Research Site, Sunrise

33634

Clinical Research Site, Tampa

33709

Clinical Research Site, St. Petersburg

34105

Clinical Research Site, Naples

34655

Clinical Research Site, Trinity

34741

Clinical Research Site, Kissimmee

34761

Clinical Research Site, Ocoee

45459

Clinical Research Site, Dayton

48532

Clinical Research Site, Miami

Clinical Research Site, Flint

53188

Clinical Research Site, Waukesha

63005

Clinical Research Site, Chesterfield

67214

Clinical Research Site, Wichita

75071

Clinical Research Site, McKinney

75149

Clinical Research Site, Mesquite

77074

Clinical Research Site, Houston

77429

Clinical Research Site, Cypress

77479

Clinical Research Site, Sugar Land

78229

Clinical Research Site, San Antonio

78737

Clinical Research Site, Austin

83704

Clinical Research Site, Boise

84088

Clinical Research Site, West Jordan

85351

Clinical Research Site, Sun City

85710

Clinical Research Site, Tucson

89106

Clinical Research Site, Las Vegas

90064

Clinical Research Site, Los Angeles

90720

Clinical Research Site, Los Alamitos

91910

Clinical Research Site, Chula Vista

92056

Clinical Research Site, Oceanside

92103

Clinical Research Site, San Diego

Clinical Research Site, Honolulu

92251

Clinical Research Site, Imperial

92591

Clinical Research Site, Temecula

92705

Clinical Research Site, Santa Ana

94549

Clinical Research Site, Lafayette

98201

Clinical Research Site, Everett

04401

Clinical Research Site, Bangor

01852

Clinical Research Site, Lowell

08755

Clinical Research Site, Toms River

05091

Clinical Research Site, Woodstock

V1Y 1Z9

Clinical Research Site, Kelowna

L3Y G8

Clinical Research Site, Newmarket

Sponsors
All Listed Sponsors
lead

Axsome Therapeutics, Inc.

INDUSTRY

NCT04797715 - Assessing Clinical Outcomes in Alzheimer's Disease Agitation | Biotech Hunter | Biotech Hunter